[Pharmacological and clinical profile of rosuvastatin calcium (Crestor)]

Nihon Yakurigaku Zasshi. 2005 Sep;126(3):213-9. doi: 10.1254/fpj.126.213.

[Article in Japanese]

Authors

Kazumi Ohfuji¹, Seiichi Yano, Motonori Yamaguchi, Graham Smith, Masako Hirata, Hitoshi Shimada, Koji Izuishi, Jotaro Shinagawa, Kazuki Matsunaga

Affiliation

¹ Kazumi.Ohfuji@astrazeneca.com

PMID: 16272766
DOI: 10.1254/fpj.126.213

No abstract available

Publication types

Review

MeSH terms

Animals
Cholesterol / blood
Fluorobenzenes / chemistry
Fluorobenzenes / pharmacology*
Fluorobenzenes / therapeutic use*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / drug therapy
Pyrimidines / chemistry
Pyrimidines / pharmacology*
Pyrimidines / therapeutic use*
Rats
Rosuvastatin Calcium
Sulfonamides / chemistry
Sulfonamides / pharmacology*
Sulfonamides / therapeutic use*

Substances

Fluorobenzenes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pyrimidines
Sulfonamides
Rosuvastatin Calcium
Cholesterol